Dr. Huber and Dr. Nicholson were among more than a dozen radiologists from across the country that participated in the initial clinical evaluations of Celero. Detailed profiles of the experiences of Dr. Huber and Dr. Nicholson are posted on the Suros website - www.SurosSurgical.com. Many of the hospitals and breast centers that participated in the pre-launch program have adopted the Celero for their spring loaded core procedures.
Suros President, Jim Pearson, believes that larger core samples mean the procedure will be faster for the patient, less traumatic due to fewer needle insertions, and able to provide improved diagnostic information in pathology. Pearson says, "The Celero is designed to replace current ultrasound-guided spring loaded core biopsy devices. Like spring loaded core needles, it is just as easy to use for physicians and technologists, but we believe our product offers a better clinical solution."

More than 550,000 ultrasound guided core needle biopsy procedures are performed annually, primarily with spring loaded core devices. The number of diagnostic breast biopsies is increasing every year. A report in the September 2006 issue of the Journal of the American College of Radiology indicates a 61 percent increase in biopsy procedures and procedure volumes going up by 101 percent among radiologists compared to surgeons. "With 80 percent of those biopsies resulting in a negative diagnosis," Pearson says, "there is no reason why women should undergo procedures that are painful or traumatic."
About Suros Surgical Systems, Inc.
Suros Surgical Systems, Inc., a subsidiary of women's imaging leader, Hologic, Inc, (NASDAQ: HOLX), is a leading innovator in the field of devices used for minimally invasive breast biopsy and tissue excision. At Suros, we believe patients are better served with a minimally invasive approach to biopsy or surgery. That's why we specialize in fast, safe and easy interventional breast biopsy products for biopsy, tissue removal and biopsy site marking. Suros designs, manufactures and markets patient-focused and physician-inspired "Compassionate Technologies" through its ATEC® (Automated Tissue Excision and Collection) product line compatible with stereotactic x-ray, ultrasound and magnetic resonance imaging (MRI) systems and its ultrasound only Celero device. Suros is viewed worldwide as the pioneer and market leader in MRI-guided breast biopsy technology, and is the fastest growing choice in vacuum-assisted breast biopsy. For more information visit www.SurosSurgical.com.

About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C-arm and extremity MRI imaging for orthopedic applications. For more information visit www.hologic.com.

Back to HCB News

More Voices